Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 28, 2016
Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depressionKristi Pettai, Lili Milani, Anu Tammiste, et al.
Journal of Psychopharmacology (Oxford, England)|October 20, 2006
The other face of depression, reduced positive affect: the role of catecholamines in causation and cureDavid Nutt, Koen Demyttenaere, Zoltan Janka, et al.
Molecular Psychiatry|June 6, 2025
Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Human Psychopharmacology|January 16, 2014
A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteersDavid Christmas, Alison Diaper, Sue Wilson, et al.
Psychopharmacology|November 4, 2021
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyJoanna Kuc, Hannes Kettner, Fernando Rosas, et al.
European Addiction Research|August 14, 2017
A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European UnionGianLuca Quaglio, Arnt Schellekens, Matthijs Blankers, et al.
Molecular Psychiatry|April 25, 2025
Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Neuroimage|June 28, 2019
Spectral signatures of serotonergic psychedelics and glutamatergic dissociativesCarla Pallavicini, Martina G Vilas, Mirta Villarreal, et al.
Journal of Analytical Toxicology|November 6, 2015
Validated Method for the Quantification of Baclofen in Human Plasma Using Solid-Phase Extraction and Liquid Chromatography-Tandem Mass SpectrometryLimon Khatun Nahar, Rosa Elena Cordero, David Nutt, et al.
Neuropsychologia|April 10, 2016
A placebo-controlled investigation of synaesthesia-like experiences under LSDDevin B Terhune, David P Luke, Mendel Kaelen, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 28, 2016
Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depressionKristi Pettai, Lili Milani, Anu Tammiste, et al.
Journal of Psychopharmacology (Oxford, England)|October 20, 2006
The other face of depression, reduced positive affect: the role of catecholamines in causation and cureDavid Nutt, Koen Demyttenaere, Zoltan Janka, et al.
Molecular Psychiatry|June 6, 2025
Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Human Psychopharmacology|January 16, 2014
A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteersDavid Christmas, Alison Diaper, Sue Wilson, et al.
Psychopharmacology|November 4, 2021
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyJoanna Kuc, Hannes Kettner, Fernando Rosas, et al.
European Addiction Research|August 14, 2017
A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European UnionGianLuca Quaglio, Arnt Schellekens, Matthijs Blankers, et al.
Molecular Psychiatry|April 25, 2025
Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Neuroimage|June 28, 2019
Spectral signatures of serotonergic psychedelics and glutamatergic dissociativesCarla Pallavicini, Martina G Vilas, Mirta Villarreal, et al.
Journal of Analytical Toxicology|November 6, 2015
Validated Method for the Quantification of Baclofen in Human Plasma Using Solid-Phase Extraction and Liquid Chromatography-Tandem Mass SpectrometryLimon Khatun Nahar, Rosa Elena Cordero, David Nutt, et al.
Neuropsychologia|April 10, 2016
A placebo-controlled investigation of synaesthesia-like experiences under LSDDevin B Terhune, David P Luke, Mendel Kaelen, et al.
Pageof 18